SIRT1: new avenues of discovery for disorders of oxidative stress - Test2 - elhamkhani - TriplyDB

SIRT1: new avenues of discovery for disorders of oxidative stress

SIRT1: new avenues of discovery for disorders of oxidative stress

http://www.wikidata.org/entity/Q35757288

about

Novel nervous and multi-system regenerative therapeutic strategies for diabetes mellitus with mTOR Erythropoietin and diabetes mellitus Stem cell guidance through the mechanistic target of rapamycin FoxO Transcription Factors and Regenerative Pathways in Diabetes Mellitus Erythropoietin: new directions for the nervous system Cutting through the complexities of mTOR for the treatment of stroke Targeting disease through novel pathways of apoptosis and autophagy Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin Erythropoietin and mTOR: A "One-Two Punch" for Aging-Related Disorders Accompanied by Enhanced Life Expectancy New Insights for Oxidative Stress and Diabetes Mellitus Novel applications of trophic factors, Wnt and WISP for neuronal repair and regeneration in metabolic disease Radioprotective and antioxidant effect of resveratrol in hippocampus by activating Sirt1 Transcriptional control of antioxidant defense by the circadian clock Alpha-lipoic acid as a pleiotropic compound with potential therapeutic use in diabetes and other chronic diseases.WISP1: Clinical insights for a proliferative and restorative member of the CCN family PRAS40 is an integral regulatory component of erythropoietin mTOR signaling and cytoprotection Taking aim at Alzheimer's disease through the mammalian target of rapamycin Resveratrol relieves ischemia-induced oxidative stress in the hippocampus by activating SIRT1 WISP1 (CCN4) autoregulates its expression and nuclear trafficking of β-catenin during oxidant stress with limited effects upon neuronal autophagy.Mammalian target of rapamycin signaling in diabetic cardiovascular disease Regeneration in the nervous system with erythropoietin A Critical Kinase Cascade in Neurological Disorders: PI 3-K, Akt, and mTOR.Oxidant stress and signal transduction in the nervous system with the PI 3-K, Akt, and mTOR cascade Tissue-specific implications of mitochondrial alterations in aging.Novel directions for diabetes mellitus drug discovery Age-associated molecular changes in the kidney in aged mice.Expression and clinical significance of Sirt1 in colorectal cancer.Signaling molecules involved in lipid-induced pancreatic beta-cell dysfunction.WISP1 neuroprotection requires FoxO3a post-translational modulation with autoregulatory control of SIRT1 Crosstalk between poly(ADP-ribose) polymerase and sirtuin enzymes.Forkhead transcription factors: new considerations for alzheimer's disease and dementia.Common SIRT1 variants modify the effect of abdominal adipose tissue on aging-related lung function decline.Effects of Resveratrol and trans-3,5,4'-Trimethoxystilbene on Glutamate-Induced Cytotoxicity, Heme Oxygenase-1, and Sirtuin 1 in HT22 Neuronal Cells Sirtuin 1 activation protects against early brain injury after experimental subarachnoid hemorrhage in rats.Sirt1 regulates glial progenitor proliferation and regeneration in white matter after neonatal brain injury.Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications.Programming apoptosis and autophagy with novel approaches for diabetes mellitus.Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders.Moving to the Rhythm with Clock (Circadian) Genes, Autophagy, mTOR, and SIRT1 in Degenerative Disease and Cancer.Harnessing the Power of SIRT1 and Non-coding RNAs in Vascular Disease.

P2860

Q26749047-20C7BD27-9F57-47B6-B8C1-7A6D8919064A Q26777878-AEB62046-94A1-4D12-8D2F-69366ABC9F73 Q26795544-5FDBBBA8-27F6-4DF3-BC2E-F961274B6865 Q26800615-3ECA8E97-FE23-43D6-AC9C-8D8C13D32FE2 Q26828425-DB13542B-9C67-4F63-86BE-1E5ABA84F8A5 Q26851291-5727B79E-DAD3-41C9-B1B5-BDB448381149 Q26864639-9F678708-B842-4D9C-96E3-B24D6005E304 Q27015640-9709B3A6-ECF3-48AB-9334-7499F07078B5 Q28066377-3695D293-916B-447E-B980-D2DFD7FCCC9C Q28080679-7A82BA4A-74AA-4FEC-A516-70A13340B4BA Q28085715-B5EC4833-0639-451E-AD72-C319AEF14F4C Q33580535-7243BBA9-F187-44F2-900F-8D525A681CC6 Q33687785-999396BE-EF63-47BD-806C-909EA9949C33 Q34012029-A5396808-D3C9-41C6-8C88-EED4DCEC5F66 Q34381111-8E9E6EC7-F67A-4400-B0CF-A6E431BCD046 Q34429082-1C274EB4-D40A-46BF-AB4B-72C5134952B7 Q34603651-866C1C51-2558-497E-9C83-A9AE88F08DFB Q35871414-D970E5D2-95F3-48FC-B7FF-2EFD5C0BED38 Q35965763-3CE8B965-EAC5-4E86-BFA0-E8045668C79F Q36100715-C1CEC952-083E-4756-9479-EC3388B4BE15 Q36247651-4ABAAA9A-801F-49F5-B07B-602C3BD99036 Q36379761-D175BE72-0998-4215-8C88-FBC7281798CF Q36432388-817962E7-FB1A-4D83-9939-3102F86D1FBC Q36444696-FE3F9103-0ED9-4D5F-ADB1-F943549B1FA6 Q36487424-F53BA5C5-4971-49AA-AC7F-37AE8A3A4A50 Q36530225-51C91349-ADA9-4B3D-84A3-4BA2BF646780 Q36535664-AC72A8EF-3F86-41FC-9148-A279A6419BA2 Q36568896-08DDC974-9B98-436E-BC6B-B114FE88E98C Q36597808-44D44B0A-F6B2-407A-B8E6-32BF617C0954 Q36913813-91E398A5-9663-41F3-846D-18EFC7931E65 Q37064987-AF5F094E-7588-4D83-9068-6BF3B1A00B61 Q37219644-CB3592B3-93A6-4EE8-A3A8-58A6A6A6A2C0 Q37224583-95089C2C-9F7F-4B4B-99E3-F3CF33FFF73B Q37465847-55A5588D-E6CC-40E9-84B0-DD6D8865929A Q37533313-8B121E12-68FA-440A-BCF7-E1BFF9ECA024 Q38134049-B0C73C64-34ED-4665-98E0-350767577130 Q38367977-F408D0FE-AD9E-4740-9CCF-FC9DEA15E3C6 Q38607849-3B463887-1042-4117-99F7-46B35655D2FC Q38655453-4B893A75-4836-44C3-A4D7-C18A5A0C8AB5 Q38789540-5ED014AD-3118-4F54-8382-8CE030F090FD

P2860

SIRT1: new avenues of discovery for disorders of oxidative stress

http://www.wikidata.org/entity/Q35757288

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

SIRT1: new avenues of discovery for disorders of oxidative stress

@ast

SIRT1: new avenues of discovery for disorders of oxidative stress

@en

type

label

SIRT1: new avenues of discovery for disorders of oxidative stress

@ast

SIRT1: new avenues of discovery for disorders of oxidative stress

@en

prefLabel

SIRT1: new avenues of discovery for disorders of oxidative stress

@ast

SIRT1: new avenues of discovery for disorders of oxidative stress

@en

P1433

Q35757288-6CB3F92A-D3C5-44A8-A878-241FABCFE21B

P1476

Q35757288-2F92D983-FB30-490A-B1D1-E5A4AB4358C2

P2093

Q35757288-007A2B11-35A8-480C-8FB4-8E82A2DAF638

Q35757288-7CFDC231-D681-469F-BA35-8CF4BA819ACB

Q35757288-D435A5E5-E871-4BA5-8472-8697A876E923

Q35757288-E367F0D3-F7BB-4DC8-86A3-2F42166501FD

P2860

Q35757288-0755A8A7-B382-4A91-951E-C30B2FE5C942

Q35757288-093C816C-2024-4A52-AB3C-B8A686B5D2A2

Q35757288-09E992A4-567F-49FC-A3EE-00BF4DE92236

Q35757288-0DA1905B-B9BB-47FE-9AF6-6BCAE7DF8374

Q35757288-0F0DD190-A360-478A-B1BC-EAD1172B4191

Q35757288-11CCB07F-515A-40AC-8675-C3CE4867E507

Q35757288-15FE76FF-7C79-40CD-8A1E-805D38233462

Q35757288-16CEEC1B-DBA4-4F91-8C29-80A6238C6D93

Q35757288-1972C383-CF47-4C9A-9E73-6A10C240A980

Q35757288-1BA13DBE-19D2-4920-A1D3-19A6DB48E179

P304

Q35757288-5F919C70-2175-416A-8FB3-BF434F3D5B9A

P31

Q35757288-CA6C3106-ECB2-43DB-ACDF-6B315C4A8008

P356

Q35757288-D64F9810-F844-4B4F-ABCB-6F5348108153

P407

Q35757288-91E7D4EE-FAD5-44FA-8338-9085F8CA57F7

P433

Q35757288-9860053A-F5A2-492E-BAA2-33258772AA4D

P478

Q35757288-42A2870D-A8B9-40DC-A398-C6585C101003

P577

Q35757288-9F11294F-DCCE-49CD-A579-C0B8344837F4

P5875

Q35757288-54F0AFE9-F113-44E4-986A-C435655BE5CB

P698

Q35757288-42D1373A-8C29-4BC1-8B65-CB64C0FBD74A

P932

Q35757288-DBC64214-EA2E-452F-A8F0-DD5F0E1F2C5F

P356

14728222.2012.648926

P1433

Expert Opinion on Therapeutic Targets

P1476

SIRT1: new avenues of discovery for disorders of oxidative stress

@en

P2093

Kenneth Maiese

http://www.w3.org/2001/XMLSchema#string

Shaohui Wang

http://www.w3.org/2001/XMLSchema#string

Yan Chen Shang

http://www.w3.org/2001/XMLSchema#string

Zhao Zhong Chong

http://www.w3.org/2001/XMLSchema#string

P2860

Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase.

Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma

Phosphorylation of HuR by Chk2 regulates SIRT1 expression

Silent information regulator 2 potentiates Foxo1-mediated transcription through its deacetylase activity

Active regulator of SIRT1 cooperates with SIRT1 and facilitates suppression of p53 activity

Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage

DBC1 is a negative regulator of SIRT1

Enzymes in the NAD+ salvage pathway regulate SIRT1 activity at target gene promoters

The deacetylase SIRT1 promotes membrane localization and activation of Akt and PDK1 during tumorigenesis and cardiac hypertrophy

SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation

P304

167-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14728222.2012.648926

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2012-01-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221736531

http://www.w3.org/2001/XMLSchema#string

P698

22233091

http://www.w3.org/2001/XMLSchema#string

P932

3279588

http://www.w3.org/2001/XMLSchema#string